Human Platelet Lysate Market

Human platelet lysate (HPL) is a non-animal derived cell culture growth supplement obtained from blood platelets after freezing and thawing. HPL contains abundant growth factors and cytokines necessary for cell growth and proliferation. Platelet lysate can be used as a source of growth factors to replace bovine serum in cell culture medium. Replacing bovine serum with HPL allows expansion and clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens.
Human Platelet Lysate Market contains market size and forecasts of Human Platelet Lysate in global, including the following market information:
Global Human Platelet Lysate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Platelet Lysate Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Human Platelet Lysate companies in 2021 (%)
The global Human Platelet Lysate market was valued at 2587.8 million in 2021 and is projected to reach US$ 2974.2 million by 2028, at a CAGR of 2.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Heparin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Platelet Lysate include Mill Creek Life Sciences, Merck & Co., Inc, STEMCELL Technologies Inc, AventaCell BioMedical, Compass Biomedical, Inc, Macopharma SA, Trinova Biochem GmbH, PL BioScience GmbH and Cook Regentec. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Platelet Lysate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Platelet Lysate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Human Platelet Lysate Market Segment Percentages, by Type, 2021 (%)
Heparin
Heparin Free
Global Human Platelet Lysate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Human Platelet Lysate Market Segment Percentages, by Application, 2021 (%)
Contract Research Organizations
Academic & Research Institutes
Pharmaceutical Companies
Others
Global Human Platelet Lysate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Human Platelet Lysate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Platelet Lysate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Platelet Lysate revenues share in global market, 2021 (%)
Key companies Human Platelet Lysate sales in global market, 2017-2022 (Estimated), (MT)
Key companies Human Platelet Lysate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mill Creek Life Sciences
Merck & Co., Inc
STEMCELL Technologies Inc
AventaCell BioMedical
Compass Biomedical, Inc
Macopharma SA
Trinova Biochem GmbH
PL BioScience GmbH
Cook Regentec